½ÃÀ庸°í¼­
»óǰÄÚµå
1612173

¼¼°èÀÇ Ç÷°ü Çö¹Ì°æ ½ÃÀå : »ç¿ë¼ºº°, ÃÖÁ¾ »ç¿ëÀÚº° - ¿¹Ãø(2025-2030³â)

Angioscope Device Market by Usability (Disposable Angioscopes, Reusable Angioscopes), End User (Diagnostic Centers, Hospitals, Research & Academic Institutes) - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 186 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Ç÷°ü Çö¹Ì°æ ½ÃÀåÀº 2023³â¿¡ 2¾ï 5,158¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 2¾ï 6,677¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, CAGR 6.50%·Î ¼ºÀåÇÒ Àü¸ÁÀ̰í, 2030³â¿¡´Â 3¾ï 9,120¸¸ ´Þ·¯¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Ç÷°ü Çö¹Ì°æÀº Ç÷°ü ³»ºÎ¸¦ ½Ã°¢È­ÇÏ´Â µ¥ »ç¿ëµÇ´Â ÀÇ·á±â±âÀÌ¸ç ´Ù¾çÇÑ Ç÷°ü ÁúȯÀÇ Áø´Ü°ú Ä¡·á¿¡ ÇʼöÀûÀÔ´Ï´Ù. Ç÷°ü Çö¹Ì°æÀÇ Çʿ伺Àº Á¤È®Çϰí Àúħ½ÀÀûÀÎ ±â¼úÀÌ ³ô°Ô Æò°¡µÇ´Â ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡¿¡¼­ ºñ·ÔµË´Ï´Ù. º´¿ø, ¿Ü°ú¼¾ÅÍ, ¿¬±¸±â°ü µî¿¡¼­ Æø³Ð°Ô ÀÀ¿ëµÇ¾î ½Ç½Ã°£ È­»óÀ» Á¦°øÇÔÀ¸·Î½á Ç÷°üÇü¼º¼úÀ̳ª Ç÷°ü¼ö¼ú µîÀÇ ¼Õ±â¼ú¿¡ µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÀÌÀåÄ¡ÀÇ ÃÖÁ¾ ¿ëµµ¿¡´Â, ½ÉÀ庴ÇÐ, ½Å°æÇÐ, ¸»ÃÊ Ç÷°ü Áúȯ Ä¡·áµîÀÌ Æ÷ÇԵǾî ÀÎÅͺ¥¼Å³Î ÀÇ·á óġ¿¡ ºÒ°¡°áÇÑ °ÍÀ¸·Î µÇ¾î ÀÖ½À´Ï´Ù. ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ¿øµ¿·ÂÀº °íµµÀÇ Áø´Ü µµ±¸¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, Ç÷°ü ÁúȯÀÇ ÀÌȯÀ² Áõ°¡, Á¤È®µµ¸¦ ³ôÀ̱â À§ÇÑ È­»ó ó¸® ´É·Â Çâ»ó°ú AI¿ÍÀÇ ÅëÇÕ µîÀÇ ±â¼ú Áøº¸ÀÔ´Ï´Ù. ¿Ü·¡ Áø·á¿¡ ÀûÇÕÇÑ ÈÞ´ë¿ëÀ¸·Î »ç¿ëÀÚ Ä£È­ÀûÀÎ ±â±âÀÇ °³¹ßÀ̳ª Ç÷°ü ºÐ¼®ÀÌ Áß¿äÇÑ ½Å°æÇÐÀ̳ª Á¾¾çÇп¡¼­ÀÇ ¿ëµµ È®´ë µî, ºñÁî´Ï½º Âù½º´Â dzºÎÇÏ°Ô ÀÖ½À´Ï´Ù. ½ÃÀå ÁøÀÔ ±â¾÷¿¡ ´ëÇÑ ÁÖ¿ä Á¦¾ðÀ¸·Î´Â ±â±âÀÇ È¿À²¼º°ú ¹ü¿ë¼ºÀ» ³ôÀ̱â À§ÇÑ ¿¬±¸°³¹ß ÅõÀÚ, ÀÓ»ó½ÃÇèÀ» À§ÇÑ ÇコÄÉ¾î ±â°ü°úÀÇ Á¦ÈÞ ¸ð»ö, ¾Ï¸ä ¸ÞµðÄà ´ÏÁî°¡ ÀÖ´Â ½ÅÈï½ÃÀå¿¡ ´ëÇÑ ÁÖ·Â µîÀ» µé ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª ½ÃÀå ¼ºÀåÀº °í¾×ÀÇ ±â±â ºñ¿ë, ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°Ç, ÀÌ·¯ÇÑ º¹ÀâÇÑ ±â±â¸¦ Á¶ÀÛÇÏ´Â ¼÷·ÃµÈ Àü¹®°¡ÀÇ Çʿ伺 µîÀÇ °úÁ¦¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. Á¦ÇÑ »çÇ×À¸·Î´Â °¡´Â Ç÷°üÀ̳ª º¹ÀâÇÑ Ç÷°ü¿¡¼­´Â È­»ó ó¸® ´É·Â¿¡ ÇѰ谡 Àֱ⠶§¹®¿¡ ¿ÀÁøÀÇ °¡´É¼ºÀÌ ÀÖ´Ù´Â Á¡, ¼Õ±â¼ú¿¡ ÀÇÇÑ ÇÕº´ÁõÀÇ À§ÇèÀÌ ÀÖ´Ù´Â Á¡ µîÀ» µé ¼ö ÀÖ½À´Ï´Ù. Çõ½ÅÀ» À§ÇÑ ÃÖ¼±ÀÇ ºÐ¾ß´Â ħ½ÀÀû ±â¼ú°ú ºñħ½ÀÀû ±â¼úÀ» °áÇÕÇÑ ´Ù±â´É ±â±â °³¹ß ¹× ¿¹Ãø ºÐ¼®°ú Áø´Ü Á¤È®µµ Çâ»óÀ» À§ÇÑ AI Ȱ¿ë¿¡ ÀÖ½À´Ï´Ù. ½ÃÀåÀº ¿ªµ¿ÀûÀÌ°í ±Þ¼ÓÇÑ ±â¼ú ÅëÇÕ°ú ±ÔÁ¦ »óȲÀÇ ÁøÈ­°¡ ÀÖÀ¸¸ç ±â¾÷Àº °æÀï·ÂÀ» À¯ÁöÇϱâ À§ÇØ ½Å¼ÓÇÏ°Ô ÀûÀÀÇØ¾ß ÇÕ´Ï´Ù. Çõ½Å¿¡ ´ëÇÑ Àû±ØÀûÀÎ ´ëó¿Í Àü·«ÀûÀÎ Áö¸®Àû È®´ë´Â ÇâÈÄ ¼ºÀåÀ» À§ÇÑ Áß¿äÇÑ Àü·«ÀÔ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023³â) 2¾ï 5,158¸¸ ´Þ·¯
ÃßÁ¤³â(2024³â) 2¾ï 6,677¸¸ ´Þ·¯
¿¹Ãø³â(2030³â) 3¾ï 9,120¸¸ ´Þ·¯
CAGR(%) 6.50%

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â Ç÷°ü Çö¹Ì°æ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

Ç÷°ü Çö¹Ì°æ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ ÀÛ¿ë¿¡ ÀÇÇØ º¯È­¸¦ °Þ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÅõÀÚ°áÁ¤, Àü·«Àû ÀÇ»ç°áÁ¤, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ ȹµæÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ» »Ó¸¸ ¾Æ´Ï¶ó, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¶Ç´Â ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ½ÉÇ÷°ü Áúȯ Áõ°¡
    • Ç÷°ü°æ µð¹ÙÀ̽ºÀÇ Áö¼ÓÀûÀÎ ±â¼ú Çõ½Å
    • Àúħ½À ¼ö¼ú¿¡ ´ëÇÑ ±âÈ£ÀÇ °íÁ¶
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • º¹ÀâÇÑ Ç÷°ü Çö¹Ì°æ ½Ã½ºÅÛ¿¡ °üÇÑ ±â¼úÀû °úÁ¦¿Í ǰÁú¿¡ ´ëÇÑ ¿ì·Á
  • ½ÃÀå ±âȸ
    • °í±Þ À̹Ì¡ ±â¼ú °³¹ß
    • ¿þ¾î·¯ºí ¹× ÈÞ´ë¿ë ¼Ö·ç¼ÇÀÇ ¿¬±¸ °³¹ß
  • ½ÃÀåÀÇ °úÁ¦
    • ÀÇ·á±â±âÀÇ ½ÂÀο¡ °üÇÑ ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°Ç

Porter's Five Forces : Ç÷°ü Çö¹Ì°æ ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲÀÇ °æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ޱ¸ÇÏ´Â ¸íÈ®ÇÑ ±â¼úÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®¸¦ ÅëÇØ ±â¾÷Àº ÀÚ»çÀÇ °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ °úÁ¦¸¦ ÇÇÇÒ ¼ö ÀÖÀ¸¸ç, º¸´Ù °­ÀÎÇÑ ½ÃÀå¿¡¼­ÀÇ Æ÷Áö¼Å´×À» º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : Ç÷°ü Çö¹Ì°æ ½ÃÀå¿¡¼­ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº Ç÷°ü Çö¹Ì°æ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹»óµÇ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : Ç÷°ü Çö¹Ì°æ ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

Ç÷°ü Çö¹Ì°æ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü µî ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï Æ÷Áö¼Å´×À» ¹àÈú ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í º¥´õµéÀº °æÀïÀÌ Ä¡¿­ÇØÁö´Â °¡¿îµ¥ ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : Ç÷°ü Çö¹Ì°æ ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â Ç÷°ü Çö¹Ì°æ ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °ø±Þ¾÷üÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ °ø±Þ¾÷ü¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ : Ç÷°ü Çö¹Ì°æ ½ÃÀå¿¡¼­ ¼º°ø¿¡ ´ëÇÑ ±æÀ» ±×¸³´Ï´Ù.

Ç÷°ü Çö¹Ì°æ ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÎ ¿ä¼ÒÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ´É·Â ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í °³¼±À» À§ÇØ ³ë·ÂÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·ÂÀ» Æò°¡ÇÕ´Ï´Ù.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, ¿¬±¸°³¹ß Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð ¹× ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ ¹× ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À² ¹× °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ½ÉÇ÷°ü ÁúȯÀÇ ¹ßº´·ü »ó½Â
      • Ç÷°ü Çö¹Ì°æ ±â±âÀÇ Áö¼ÓÀûÀÎ ±â¼ú Çõ½Å
      • Àúħ½À ¼ö¼ú¿¡ ´ëÇÑ °ü½É °íÁ¶
    • ¾ïÁ¦¿äÀÎ
      • º¹ÀâÇÑ Ç÷°ü°æ ½Ã½ºÅÛ°ú °ü·ÃµÈ ±â¼úÀû °úÁ¦¿Í ǰÁú¿¡ ´ëÇÑ ¿ì·Á
    • ±âȸ
      • °í±Þ À̹ÌÁö ±â¼ú °³¹ß
      • ¿þ¾î·¯ºí ¹× ÈÞ´ë¿ë ¼Ö·ç¼ÇÀÇ ¿¬±¸ °³¹ß ÀÌ´Ï¼ÅÆ¼ºê
    • °úÁ¦
      • ÀÇ·á±â±âÀÇ ½ÂÀο¡ °üÇÑ ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°Ç
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
    • »ç¿ë¼ºº° : Æí¸®¼º°ú ºñ¿ëÀÇ °üÁ¡¿¡¼­ Àç»ç¿ë °¡´ÉÇÑ Ç÷°ü Çö¹Ì°æ ¼±È£ °æÇâ °íÁ¶
    • ÃÖÁ¾ »ç¿ëÀÚº° : È¿À²ÀûÀΠȯÀÚ Æò°¡¸¦ À§ÇÑ Áø´Ü¼¾ÅÍ¿¡¼­ÀÇ ´Ù¾çÇÑ ¿ëµµ
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå Ç÷°ü Çö¹Ì°æ ½ÃÀå : »ç¿ë¼ºº°

  • ÀÏȸ¿ë Ç÷°ü Çö¹Ì°æ
  • Àç»ç¿ë °¡´ÉÇÑ Ç÷°ü Çö¹Ì°æ

Á¦7Àå Ç÷°ü Çö¹Ì°æ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • Áø´Ü¼¾ÅÍ
  • º´¿ø
  • Á¶»ç ¹× Çмú±â°ü
  • Àü¹® Ŭ¸®´Ð

Á¦8Àå ¾Æ¸Þ¸®Ä«ÀÇ Ç÷°ü Çö¹Ì°æ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦9Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Ç÷°ü Çö¹Ì°æ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦10Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Ç÷°ü Çö¹Ì°æ ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦11Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
    • AbbottÀÌ Àεµ¿¡¼­ AI °­È­ Ç÷°ü È­»ó Áø´ÜÀ» µµÀÔ, ½ÉÀå Äɾ Çõ¸íÀ» ÀÏÀ¸Å²´Ù
    • Canon Medical, À¯·´ ½ÃÀå¿¡¼­ ¾Æ¸£Æä´Ð½º ¿¡º¼ºê ¿¡µð¼Ç Ç÷°ü Á¶¿µ ½Ã½ºÅÛÀ» ¹ß¸Å
    • Abbott, Ç÷°ü Ä¡·á ±â¼ú °­È­¸¦ À§ÇØ Ä«µð¿À ¹ö½ºÅ§·¯ ½Ã½ºÅÛÁî»ç¸¦ Àμö
  • Àü·« ºÐ¼® ¹× Á¦¾È

±â¾÷ ¸ñ·Ï

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Canon Medical Systems
  • Cardinal Health
  • Cook Medical
  • Fujifilm Holdings Corporation
  • GE Healthcare
  • Hitachi Medical Corporation
  • Johnson & Johnson Services, Inc.
  • Karl Storz
  • LivaNova PLC
  • Medtronic PLC
  • Olympus Corporation
  • Philips Healthcare
  • Shimadzu Corporation
  • Siemens Healthineers
  • Smith & Nephew PLC
  • Stryker Corporation
  • Terumo Corporation
  • Vena Medica
  • Zimmer Biomet
AJY 24.12.24

The Angioscope Device Market was valued at USD 251.58 million in 2023, expected to reach USD 266.77 million in 2024, and is projected to grow at a CAGR of 6.50%, to USD 391.20 million by 2030.

An angioscope device is a medical instrument used to visualize the interior of blood vessels, which is crucial for diagnosing and treating various vascular conditions. The necessity of the angioscope device arises from the increasing prevalence of cardiovascular diseases, where precise and minimally invasive techniques are highly valued. It finds extensive application in hospitals, surgical centers, and research institutions, helping in procedures like angioplasty and vascular surgeries by providing real-time imagery. The device's end-use scope includes cardiology, neurology, and peripheral vascular disease treatment, making it indispensable in interventional medical procedures. Market growth is primarily driven by the rising demand for advanced diagnostic tools, increasing incidences of vascular diseases, and technological advancements such as improved imaging capabilities and integration with AI for enhanced precision. Opportunities are abundant in developing portable and user-friendly devices suited for outpatient settings and expanding applications in neurology and oncology, where vascular analysis is critical. Key recommendations for market participants include investing in R&D to enhance device efficiency and versatility, exploring partnerships with healthcare institutions for clinical trials, and focusing on emerging markets with unmet medical needs. However, market growth faces challenges like high device costs, stringent regulatory requirements, and the need for skilled professionals to operate these complex instruments. Limitations include potential misdiagnosis due to limited imaging capacity in smaller or complex vessels and the risk of procedural complications. Best areas for innovation lie in the development of multifunctional devices that combine invasive and non-invasive technologies, as well as leveraging AI for predictive analytics and improved diagnostic accuracy. The market is dynamic, with rapid technological integrations and evolving regulatory landscapes, necessitating businesses to adapt quickly to maintain a competitive edge. Active engagement in innovation and strategic geographical expansion are key strategies for future growth.

KEY MARKET STATISTICS
Base Year [2023] USD 251.58 million
Estimated Year [2024] USD 266.77 million
Forecast Year [2030] USD 391.20 million
CAGR (%) 6.50%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Angioscope Device Market

The Angioscope Device Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidence of cardiovascular diseases
    • Ongoing technological innovations in angioscope devices
    • Growing preference for minimally invasive surgeries
  • Market Restraints
    • Technical challenges and quality concerns related to intricate angioscope systems
  • Market Opportunities
    • Development of advanced imaging techniques
    • R&D initiatives in wearable and portable solutions
  • Market Challenges
    • Stringent regulatory requirements for approval of medical devices

Porter's Five Forces: A Strategic Tool for Navigating the Angioscope Device Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Angioscope Device Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Angioscope Device Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Angioscope Device Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Angioscope Device Market

A detailed market share analysis in the Angioscope Device Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Angioscope Device Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Angioscope Device Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Angioscope Device Market

A strategic analysis of the Angioscope Device Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Angioscope Device Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Becton, Dickinson and Company, Boston Scientific Corporation, Canon Medical Systems, Cardinal Health, Cook Medical, Fujifilm Holdings Corporation, GE Healthcare, Hitachi Medical Corporation, Johnson & Johnson Services, Inc., Karl Storz, LivaNova PLC, Medtronic PLC, Olympus Corporation, Philips Healthcare, Shimadzu Corporation, Siemens Healthineers, Smith & Nephew PLC, Stryker Corporation, Terumo Corporation, Vena Medica, and Zimmer Biomet.

Market Segmentation & Coverage

This research report categorizes the Angioscope Device Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Usability, market is studied across Disposable Angioscopes and Reusable Angioscopes.
  • Based on End User, market is studied across Diagnostic Centers, Hospitals, Research & Academic Institutes, and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidence of cardiovascular diseases
      • 5.1.1.2. Ongoing technological innovations in angioscope devices
      • 5.1.1.3. Growing preference for minimally invasive surgeries
    • 5.1.2. Restraints
      • 5.1.2.1. Technical challenges and quality concerns related to intricate angioscope systems
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of advanced imaging techniques
      • 5.1.3.2. R&D initiatives in wearable and portable solutions
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory requirements for approval of medical devices
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Usability: Increasing preference for reusable angioscopes due to convenience and cost considerations
    • 5.2.2. End User: Diverse scope of applications in diagnostic centers for efficient patient evaluation
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Angioscope Device Market, by Usability

  • 6.1. Introduction
  • 6.2. Disposable Angioscopes
  • 6.3. Reusable Angioscopes

7. Angioscope Device Market, by End User

  • 7.1. Introduction
  • 7.2. Diagnostic Centers
  • 7.3. Hospitals
  • 7.4. Research & Academic Institutes
  • 7.5. Specialty Clinics

8. Americas Angioscope Device Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Angioscope Device Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Angioscope Device Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. Abbott's Introduction of AI-Enhanced Vascular Imaging in India, Revolutionizing Cardiac Care
    • 11.3.2. Canon Medical Launches Alphenix Evolve Edition Angiography System in European Market
    • 11.3.3. Abbott Acquires Cardiovascular Systems, Inc. to Enhance Vascular Treatment Technologies
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Becton, Dickinson and Company
  • 3. Boston Scientific Corporation
  • 4. Canon Medical Systems
  • 5. Cardinal Health
  • 6. Cook Medical
  • 7. Fujifilm Holdings Corporation
  • 8. GE Healthcare
  • 9. Hitachi Medical Corporation
  • 10. Johnson & Johnson Services, Inc.
  • 11. Karl Storz
  • 12. LivaNova PLC
  • 13. Medtronic PLC
  • 14. Olympus Corporation
  • 15. Philips Healthcare
  • 16. Shimadzu Corporation
  • 17. Siemens Healthineers
  • 18. Smith & Nephew PLC
  • 19. Stryker Corporation
  • 20. Terumo Corporation
  • 21. Vena Medica
  • 22. Zimmer Biomet
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦